Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Topotecan × Clear all

NCT06548763 2024-08-12

Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT00267488 2012-07-11

Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer

Phase 2 Completed

70 enrolled 9 charts

Endometrial Neoplasms